Reports Document FDA Review Delays: What Drugmakers Should Know Now
FDA Law Blog: Drug Discovery
APRIL 21, 2025
One area drawing increasing attention is how these changes will affect the drug development and review process. As reported by the Wall Street Journal last week , reviews of both innovative and follow-on drugs have been caught in a traffic jam, largely due to a leadership vacuum at the Center for Drug Evaluation and Research (CDER).
Let's personalize your content